Thermo Fisher Scientific diagnostic test for COVID-19 receives emergency approval

Thermo Fisher Scientific Inc., Waltham, Mass., announces that on March 13 the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for its diagnostic test that can be used immediately by CLIA high-complexity laboratories in the United States to detect nucleic acid from SARS-CoV-2, the virus that causes COVID-19, and not for any other viruses or pathogens.